IBDEI0QN ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,13103,1,1,0)
 ;;=1^446.7
 ;;^UTILITY(U,$J,358.3,13103,1,2,0)
 ;;=2^TAKAYASU'S DISEASE
 ;;^UTILITY(U,$J,358.3,13103,2)
 ;;=^117141
 ;;^UTILITY(U,$J,358.3,13104,0)
 ;;=446.6^^78^817^21
 ;;^UTILITY(U,$J,358.3,13104,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13104,1,1,0)
 ;;=1^446.6
 ;;^UTILITY(U,$J,358.3,13104,1,2,0)
 ;;=2^THROMBOT MICROANGIOPATHY
 ;;^UTILITY(U,$J,358.3,13104,2)
 ;;=^119061
 ;;^UTILITY(U,$J,358.3,13105,0)
 ;;=446.4^^78^817^22
 ;;^UTILITY(U,$J,358.3,13105,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13105,1,1,0)
 ;;=1^446.4
 ;;^UTILITY(U,$J,358.3,13105,1,2,0)
 ;;=2^WEGENER'S GRANULOMATOSIS
 ;;^UTILITY(U,$J,358.3,13105,2)
 ;;=^127623
 ;;^UTILITY(U,$J,358.3,13106,0)
 ;;=444.9^^78^817^9
 ;;^UTILITY(U,$J,358.3,13106,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13106,1,1,0)
 ;;=1^444.9
 ;;^UTILITY(U,$J,358.3,13106,1,2,0)
 ;;=2^OTH ARTERIAL EMB/THROMBOSIS
 ;;^UTILITY(U,$J,358.3,13106,2)
 ;;=^39452
 ;;^UTILITY(U,$J,358.3,13107,0)
 ;;=710.9^^78^817^10
 ;;^UTILITY(U,$J,358.3,13107,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13107,1,1,0)
 ;;=1^710.9
 ;;^UTILITY(U,$J,358.3,13107,1,2,0)
 ;;=2^OTH CONNECTIVE TISSUE DISEASE
 ;;^UTILITY(U,$J,358.3,13107,2)
 ;;=^123811
 ;;^UTILITY(U,$J,358.3,13108,0)
 ;;=453.9^^78^817^11
 ;;^UTILITY(U,$J,358.3,13108,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13108,1,1,0)
 ;;=1^453.9
 ;;^UTILITY(U,$J,358.3,13108,1,2,0)
 ;;=2^OTH VENOUS EMB/THROMBOSIS
 ;;^UTILITY(U,$J,358.3,13108,2)
 ;;=^39455
 ;;^UTILITY(U,$J,358.3,13109,0)
 ;;=441.00^^78^817^1
 ;;^UTILITY(U,$J,358.3,13109,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13109,1,1,0)
 ;;=1^441.00
 ;;^UTILITY(U,$J,358.3,13109,1,2,0)
 ;;=2^ANEURYSM,AORTIC W/ DISSECTION
 ;;^UTILITY(U,$J,358.3,13109,2)
 ;;=^35660
 ;;^UTILITY(U,$J,358.3,13110,0)
 ;;=042.^^78^818^1
 ;;^UTILITY(U,$J,358.3,13110,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13110,1,1,0)
 ;;=1^042.
 ;;^UTILITY(U,$J,358.3,13110,1,2,0)
 ;;=2^AIDS OR HIV INFECTION,SYMPTOMATIC
 ;;^UTILITY(U,$J,358.3,13110,2)
 ;;=^266500
 ;;^UTILITY(U,$J,358.3,13111,0)
 ;;=540.9^^78^818^2
 ;;^UTILITY(U,$J,358.3,13111,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13111,1,1,0)
 ;;=1^540.9
 ;;^UTILITY(U,$J,358.3,13111,1,2,0)
 ;;=2^APPENDICITIS
 ;;^UTILITY(U,$J,358.3,13111,2)
 ;;=^270195
 ;;^UTILITY(U,$J,358.3,13112,0)
 ;;=682.9^^78^818^3
 ;;^UTILITY(U,$J,358.3,13112,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13112,1,1,0)
 ;;=1^682.9
 ;;^UTILITY(U,$J,358.3,13112,1,2,0)
 ;;=2^CELLULITIS AND ABSCESS
 ;;^UTILITY(U,$J,358.3,13112,2)
 ;;=^21160
 ;;^UTILITY(U,$J,358.3,13113,0)
 ;;=576.1^^78^818^4
 ;;^UTILITY(U,$J,358.3,13113,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13113,1,1,0)
 ;;=1^576.1
 ;;^UTILITY(U,$J,358.3,13113,1,2,0)
 ;;=2^CHOLANGITIS
 ;;^UTILITY(U,$J,358.3,13113,2)
 ;;=^23291
 ;;^UTILITY(U,$J,358.3,13114,0)
 ;;=574.70^^78^818^5
 ;;^UTILITY(U,$J,358.3,13114,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13114,1,1,0)
 ;;=1^574.70
 ;;^UTILITY(U,$J,358.3,13114,1,2,0)
 ;;=2^CHOLECYSTITIS
 ;;^UTILITY(U,$J,358.3,13114,2)
 ;;=^304314
 ;;^UTILITY(U,$J,358.3,13115,0)
 ;;=571.5^^78^818^6
 ;;^UTILITY(U,$J,358.3,13115,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13115,1,1,0)
 ;;=1^571.5
 ;;^UTILITY(U,$J,358.3,13115,1,2,0)
 ;;=2^CIRRHOSIS,NON-ALCOHOLIC
 ;;^UTILITY(U,$J,358.3,13115,2)
 ;;=^24731
 ;;^UTILITY(U,$J,358.3,13116,0)
 ;;=323.9^^78^818^7
 ;;^UTILITY(U,$J,358.3,13116,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13116,1,1,0)
 ;;=1^323.9
 ;;^UTILITY(U,$J,358.3,13116,1,2,0)
 ;;=2^ENCEPHALITIS/MYELITIS
 ;;^UTILITY(U,$J,358.3,13116,2)
 ;;=^334231
 ;;^UTILITY(U,$J,358.3,13117,0)
 ;;=421.9^^78^818^8
